NCT03492307

Brief Summary

This is a pilot study comparing a weight-based high-flow nasal cannula (HFNC) protocol with the current standard HFNC protocol for children \<2yo admitted to South Shore Hospital with bronchiolitis. We currently use a flat limit of 8 liters of HFNC to support work of breathing and hypoxia in these patients. We will compare that to a weight-based protocol, which will provide 2L/kg/min of flow (flows generally between 6 and 20L/minute) to this patient population. The goal of this pilot study is to assess the feasibility of our study design. We will evaluate the functionality of a new weight-based flow protocol. We will also evaluate the functionality of a new bronchiolitis scoring tool, the Bronchiolitis Assessment Severity Score (BASS), and it's ability to guide care through the new protocol. We are also testing the feasibility of recruitment, randomization and retention. We are ultimately interested in whether a weight-based flow protocol reduces need for escalation to ICU-level care for children with moderate-severe bronchiolitis on HFNC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 10, 2018

Completed
21 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

July 29, 2021

Status Verified

July 1, 2021

Enrollment Period

1.9 years

First QC Date

April 3, 2018

Last Update Submit

July 27, 2021

Conditions

Keywords

High Flow Nasal Cannula

Outcome Measures

Primary Outcomes (2)

  • Treatment failure

    Need for escalation to NIV (CPAP or BIPAP) or intubation

    During hospital admission

  • Length of Stay

    Length of hospital stay (admission to discharge or transfer)

    During hospital admission

Study Arms (2)

Standard Flow Protocol

ACTIVE COMPARATOR

Patients randomized to this arm will receive HFNC according to our current protocol with a maximum of 8L/min.

Other: Standard Flow for HFNC (Maximum 8L/minute)

Weight-Based Flow Protocol

EXPERIMENTAL

Patients randomized to this arm will receive HFNC according to a weight-based algorithm at 2L/kg/min.

Other: Weight-Based Flow for High Flow Nasal Cannula (HFNC) (2L/kg/minute)

Interventions

A weight-based flow for HFNC.

Weight-Based Flow Protocol

Maximum flow of 8L/minute.

Standard Flow Protocol

Eligibility Criteria

AgeUp to 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • admission to inpatient pediatrics
  • clinical diagnosis of bronchiolitis
  • BASS score of moderate or severe

You may not qualify if:

  • non-english speakers
  • patients with urgent need for CPAP, BIPAP or intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Shore Hospital

Weymouth, Massachusetts, 02190, United States

Location

Related Publications (1)

  • Smith A, Banville D, O'Rourke C, Melvin P, Batey L, Borgmann A, Waltzman M, Agus MSD. Randomized Trial of Weight-Based Versus Fixed Limit High-Flow Nasal Cannula in Bronchiolitis. Hosp Pediatr. 2023 May 1;13(5):387-393. doi: 10.1542/hpeds.2022-006656.

MeSH Terms

Conditions

Bronchiolitis

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Study Officials

  • Alla Smith, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2018

First Posted

April 10, 2018

Study Start

May 1, 2018

Primary Completion

March 30, 2020

Study Completion

March 30, 2020

Last Updated

July 29, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations